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4ABSTRACT
Type I diabetes (T1D) is an autoimmune disease resulting in gradual cell-mediated
destruction of insulin producing beta cells in the pancreatic islets of Langerhans. The
most plausible environmental triggers to launch and/or accelerate this process in a
genetically predisposed organism include enterovirus infections and oxidative stress.
Among other enteroviruses the group B of coxsackieviruses is associated with
potential beta cell toxicity. Beta cells are weak in antioxidative defense, which makes
them hypersensitive to oxidative stress. The viral and oxidative hazards may interact
in an additive fashion in suitable conditions and result in cumulative damage.
However, prior to the present study the mechanisms of the resulting beta cell damage
were poorly characterized. Thus, this study was set to clarify the patterns and
consequences of coxsackie B virus infections and the effects of experimental
oxidative stress in various cell culture models to understand the mechanistic pattern of
beta cell damage and death.
The performed experiments were planned with the particular intention to detect
different forms of beta cell death due to varying viral and oxidative conditions. We
chose the coxsackie B strain (CVB) because of its aggressive nature in cell systems
and the previously characterized epidemiologic link to T1D. Acknowledging the
inhibitory potential of in vivo conditions we developed two models resembling a
slowly progressing coxsackievirus infection first, by restricting the production of viral
progeny with a selective inhibitor of viral RNA replication and second, by means of
lowering the multiplicity of infection (comparable to the amount of infective viral
particles per cell). Hydrogen peroxide was selected to serve as the oxidative stressor
because it represents a physiological agent present during most oxidative processes in
vivo. L-cysteine, the precursor of the most important intracellular antioxidant
glutathione, was chosen to counteract hydrogen peroxide.
This study shows that a productive CVB-infection results in lytic beta cell death.
When pharmacologically restricted by guanidine-HCl, the viability increases
dramatically through decreased necrosis and associates with simultaneous stimulation
of apoptotic death. A similar pattern of host cell death characterizes a CVB5 infection
of low multiplicity. L-cysteine protects dose-dependently against hydrogen peroxide
5induced damage. Also apoptosis provoked by a moderate level of hydrogen peroxide
is reversed by L-cysteine. The intracellular glutathione content transiently decreases
during a low multiplicity CVB5 infection, but shows full recovery at later timepoints.
This might imply a more physiological type of damage, which has previously been
linked to induction of apoptotic cell death. Furthermore, the glutathione machinery
might have a protective role against damage induced by coxsackievirus infection.
In conclusion, this study introduces potential mechanistic models for enterovirus
infections in beta cells. It points to apoptosis as a favored outcome during a slowly
progressing prototype coxsackievirus B5 infection, which is in contrast to the lytic
beta cell death that dominates a freely progressing, high multiplicity coxsackievirus
B5 infection. Moreover, when correctly administered, substituent antioxidants
efficiently protect insulin-producing cells against oxidative damage. Intracellular
glutathione system may also contribute to the survival of CVB-infected beta cells
independent of the pace of progression of infection.
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AA ascorbic acid
alpha-TOH alpha-tocopherol
AP-1 activator protein-1
APC antigen presenting cell
BB rat biobreeding rat
CAR coxsackie/adenoviral receptor
CAT catalase
CVA coxsackievirus A strain
CVB coxsackievirus B strain
DC dendritic cell
ERK 1/2 extracellular signal-regulated kinase 1 and 2
EthD-1 ethidium homodimer
G-HCl guanidine hydrochloride
GAD glutamic acid decarboxylase
Glut-2 glucose transporter 2
Gpx glutathione peroxidase
GSH glutathione
GSSG oxidized glutathione
HIV human immunodeficiency virus
HLA human leukocyte antigen
HO Hoechst dye 33342
HO-1 heme oxygenase-1
T1D type I, insulin dependent, diabetes mellitus
IFN interferon
IL-1ß interleukine 1 beta
iNOS inducible nitric oxide synthase
IRES internal ribosome entry site
Isl-1 islet-1 transcription factor
KRB Krebs-Ringer bicarbonate buffer
LA R-alpha-Lipoic acid
MAPK mitogen activated protein kinase
MHC major histocompatibility complex
M.O.I. multiplicity of infection
MTT C,N-diphenyl-N’-4,5-dimethyl-thiazol-2-yl-tetrazolium bromide
M∅ macrophage
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NF-kB nuclear factor-kappaB transcription factor
NK natural killer cell
NO nitric oxide
NOD mouse spontaneously diabetic non-obese
Pdx-1 pancreatic duodenal homeobox
ROS reactive oxygen species
SOD superoxide dismutase
STZ streptozotocin
TNF-α tumor necrosis factor alpha
TNF-R tumor necrosis factor receptor
Trx thioredoxin
VSV vesicular stomatitis virus
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INTRODUCTION
T1D is considered to represent a multifactorial disorder based on genetic predisposition
triggered by an environmental factor e.g. virus infection. The effector stage, insulitis, is
characterized by gradual invasion of macrophages, T-cells and the produced cytokines and
oxidative radicals into the islets. The prediabetic period is usually long and characterized
by formation of islet cell autoantibodies even years before the development of diabetic
symptoms. Enterovirus infections are epidemiologically linked to the pathogenesis of T1D.
Beta cells exhibit poor intracellular antioxidative capacity, which renders them vulnerable
to oxidative stress. Thus, both enterovirus infections and oxdative stress are considered to
represent particularly potential triggers and/or accelerators of beta cell destruction.
It is generally known that the amount of viral particles needed to establish a local infection
is low and all viruses invading a physiological environment face natural resistance by
factors of the hosting immune system. Considering that coxsackievirus infections most
often remain subclinical in vivo, the progression of infection and amount of virus are
possibly limited and submaximal. Thus, this study was set to first create experimental
models of slowly progressing enterovirus infection and second, to study the pattern of
mechanisms of virus induced beta cell damage. Further aims included characterizing the
mechanisms of oxidative beta cell injury, counteracting it by means of antioxidative agents
and studying the effects of virus infection on intracellular redox balance.
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REVIEW OF THE LITERATURE
1. Type I Diabetes (T1D)
1.1 Definition and pathogenesis
Juvenile, insulin-dependent diabetes mellitus (type I diabetes, T1D) is a consequence
of selective autoimmune destruction of the insulin-producing beta cells in the
pancreatic islets of Langerhans (Bach, 1994; Schranz and Lernmark, 1998). The
resulting insulin deficiency leads to a chronic metabolic derangement associated with
significant secondary morbidity. According to the traditional opinion consistent
within most autoimmune diseases, both a genetically predisposed individual and a
suitable environmental trigger are needed for the destructive process, in the case of
T1D against beta cells, to begin. Today, the group of human leukocyte antigen (HLA)
genes is considered to account for the major genetic risk and virus infections to
represent prime environmental triggers.
Multiple lines of evidence suggest that the autoimmune destruction is launched by a
local insult to islet(s) exciting a pool of immune cells, dominantly T-cells and
macrophages, to invade the islets resulting in insulitis (Gepts, 1965; Horwitz et al.
2002). Considering the pathogenesis, most results are obtained from studies in
spontaneously diabetic non-obese (NOD) mice, whose pathogenesis mimics the
human type I diabetes (Makino et al.  1980). Most probably both cytotoxic (CD8+)
and helper (CD4+) T-cells are required for both the primary attack and the later overt
destruction, respectively, to progress (Wong et al.  1996; Jarpe et al.  1990-1991;
Wicker et al.  1994; Sumida et al.  1994; Miller et al.  1988; Hanafusa et al.  1988;
Bendelac et al.  1987). Additionally, a pool of antigen presenting cells (APC) is
indispensable in the vicinity of pancreatic islets to introduce the islet antigen to the
autoreactive T-cells. According to current opinion, programmed cell death (apoptosis)
represents the dominant mechanism of beta cell death during immune mediated T1D
(Eizirik and Mandrup-Poulsen, 2001). The immune reaction related proinflammatory
cytokines, especially interferon gamma (IFN-γ), interleukine 1 beta (IL-1β) and tumor
necrosis factor alpha (TNF-α), are thought to play a primary role in activating signal
transduction pathways leading to beta cell dysfunction and apoptosis (Mandrup-
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Poulsen, 1996; Rabinovitch, 1998; Delaney et al.  1997). The direct killing through
granzyme-perforin pathway by cytotoxic T cells is also believed to be an important
mechanism leading to apoptotic beta cell death.
1.2 Genetics and epidemiology
Finland has the highest incidence of T1D in under 15-year-old children worldwide. It
has gradually increased during the last 43 years from 12/100000 (1953) to 45/100000
(1996) the average relative annual increase thus being 3.4 % between 1965 and 1996
(Somersalo O, 1955; Tuomilehto et al.  1999). The incidence is not only
geographically but also seasonally distributed peaking in winter (Levy-Marchal et al.
1995). Finland and some other Nordic high-incidence countries have also shown
gender-influence with a slight male predominance (Padaiga et al.  1997).
Approximately 10 % of newly diagnosed T1D patients have an affected first degree-
relative (Dahlquist et al.  1985; Tuomilehto et al.  1992). The genetic risk and familial
clustering of T1D has traditionally been concidered to originate from the class II
major histocompatibility complex (MHC) genes on chromosome 6p21, including
HLA DP, DQ and DR (Davies et al.  1994; Campbell and Trowsdale, 1993). These
genes encode heterodimeric proteins expressed on APC-cells and have a function in
presenting antigenic peptides to CD4+ T-cells. HLA class II genes have a high degree
of polymorphism and marked linkage disequilibrium, which potentiate the risk to
form certain high-risk allele-pairs. Furthermore, these susceptibility alleles may then
select potential autoreactive T-cells during thymic selection, and increase the disease
probability. Many recent studies have demonstrated the DQ-locus to primarily harbor
the susceptibility for T1D (Thorsby and Ronningen, 1993; Heimberg et al.  1992;
Dorman and Bunker, 2000). Specifically, worldwide approximately 30% of T1D
patients are heterozygous for the high risk HLA-DQA1*0501-DQB1*0201 /
DQA1*0301-DQB1*0302 alleles (previously referred to as HLA-DR3/4 or HLA-
DQ2/DQ8). Also lack of the protective HLA-DQA1*0102-DQB1*0602 allele (HLA-
DR2 or HLA-DQ6) increases T1D susceptibility through potentiating the effects of
predisposing alleles (Pociot and McDermott, 2002). Genes located in the HLA-region,
including genes important for structure and function of both the HLA-DQ and DR, are
considered capable of accounting for less than 50% of the inherited disease risk
(Pociot and McDermott, 2002; Thomson et al.  1988). Largely by means of genome
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scan based linkage studies of affected sib-pair families at least 17 non-HLA T1D
susceptibility loci have also been identified (Pociot and McDermott, 2002). Out of
these, the insulin gene locus (IDDM2) is the strongest and most consistent (Bennett et
al.  1995).
2. Description of cell death mechanisms and their association to T1D
Several routes and mechanisms have been described for a cell to die. The particular
pathway chosen depends mostly on the trigger, but the end result may vary according
to the cellular capacity of defense and the overall status of the host (age, inflammation
etc.). The rough division is traditionally done by the resulting morphological
characteristics: apoptotic, pyknotic, necrotic.  (Figure 1)
Figure 1.  Illustration of nuclear morphology associated with different forms
    of cell death
2.1. Necrosis
Necrotic cell death is an accidental, traumatic event always associated with some
pathology. It is an unregulated process and follows no specific pattern. The key
features include cytoplasmic and mitochondrial swelling and breakdown of cell to cell
junctions and communication which lead to early rupture of cellular membranes and
leakage of the contents to the extracellular space provoking inflammation (Lemasters,
1999; Buja et al.  1993).
Considering beta cells, detailed studies on cytokine induced stress in rat islets have
revealed nitric oxide (NO) to mediate functional deterioration and mostly necrotic
beta cell death (Hoorens et al.  2001). More recently, necrotic beta cell damage was
NECROSISAPOPTOSISVIABLE PYKNOSIS
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shown to dominate the pattern of spontaneous, NO-induced and STZ-induced diabetes
in diabetes prone BB rats (Fehsel et al.  2003). Particularly considering cell culture
models, environmental factors such as high cell density may also direct the outcome
of cell death towards necrosis.
2.2. Apoptosis
The term apoptosis descends from the Greek words: 'apo'  (away) + 'ptosis' (drop) and
characterizes a cellular suicide (Ueda and Shah, 1994). Apoptosis is a physiological,
energy-requiring, orderly phenomenon used by multicellular organisms to control the
size of cell populations and to eliminate damaged, infected or mutated cells. It is thus
crucial for proper embryonic morphogenesis, development, and adult cellular
homeostasis. The apoptotic machinery is constitutively expressed in all nucleated
animal cells and is strictly regulated by a set of evolutionarily conserved genes
(Horvitz, 1999; Vaux et al.  1992). The apoptotic process can be divided in three
stages: 1) initiation: a cell receives an apoptotic stimulus, 2) execution: enzymatic
events, and 3) degeneration: disintegration and elimination of the cell. In general,
apoptotic stimuli may activate two different pathways: an extrinsic death-receptor
pathway or an intrinsic pathway based on mitochondrial dysfunction (Hengartner,
2000). The extrinsic trail is launched by triggering of a death receptor on cell surface,
the most common of which belong to the family of tumor necrosis factor receptors
(TNF-R) (Armitage, 1994; Baker and Reddy, 1998). These receptors include a death
domain (Tartaglia et al. 1993), which is responsible for the activation of the
downstream cascade: the recruitment of intracellular adapter proteins (FADD,
TRADD, RAIDD) and the following activation of caspase (cysteine aspartic acid-
specific proteases) 8 and possibly caspase 2 (Ashkenazi and Dixit, 1998; Alnemri et
al.  1996). T-cells use alternative extrinsic routes by activating either Fas (discussed
later) or granzyme B leading to stimulation of either caspase 8 or the intrinsic
pathway (Pinkoski et al.  2001). Commonly the intrinsic route is activated by stress
factors including DNA damage, cell cycle perturbation or growth factor deprivation.
They engage pro-apoptotic members of the Bcl-2-family (Bak, Bax) to translocate to
mitochondria and form pores to permit cytochrome c to release from the
mitochondrial intermembrane space and to compose the apoptosome with Apaf-1 and
procaspase 9 (Zou et al.  1999; Rodriguez and Lazebnik, 1999). Recently, a new
mitochondrial flavoprotein (apoptosis inducing factor; AIF) was found to translocate
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to nucleus in response to e.g. oxidative apoptotic stimuli and launch caspase-
(in)dependent chromatin condensation and DNA cleavage (Susin et al.  1999). At the
final stage, both routes activate the effector caspases (3, 6 and 7), that proteolytically
activate other downstream caspases (Slee et al.  2001; Nicholson and Thornberry,
1997). Caspase 3 activates DFF/CAD, which results in DNA cleavage to n x 180 bp
fragments (Liu et al. 1997; Enari et al.  1998). This step is called 'point of no return',
since the proteolytic cascade irreversibly leads to cellular collapse featured by the
characteristic morphology: cell shrinkage, chromatin condensation, blebbing of the
plasmamembrane and formation of apoptotic bodies, which become eliminated by
neighboring phagocytes (Kerr et al.  1972; Wyllie, 1981).
Apoptotic death mediated by immune effector cells is considered to dominate beta
cell death. Several molecular pathways may be activated for this outcome to occur.
Macrophages and activated T-cells produce and secrete proinflammatory cytokines,
IL-6, IL-2, IL-10, IL-1β, TNF-α and IFN-γ, the last three of which are known for
their potential to induce functional and structural beta cell damage and to provoke
apoptosis (Marselli et al.  2000; Liu et al.  2000a; Saldeen, 2000; Zumsteg et al.
2000). A recent microarray survey on cytokine-stressed rat islets revealed the
transcription factor NF-κB to be a core regulator of cytokine induced signaling
pathways (Cardozo et al.  2001). By inhibiting its activity the cytokine induced beta
cell apoptosis could be prevented (Heimberg et al.  2001)
Attracted T-cells express Fas-ligand (FasL) on cell surface, which by binding to the
target cell Fas receptor results in apoptosis (Kagi et al.  1994). In spontaneously
diabetic NOD mice the proinflammatory cytokines may induce Fas expression in beta
cells and thus contribute to beta cell death through interaction with FasL on the
surface of the neighboring CD4+ T-cells (Nakayama et al.  2002; Suarez-Pinzon et al.
1999; Suarez-Pinzon et al.  2000; Augstein et al.  2003; Petrovsky et al.  2002). Also
human beta cells in pancreatic biopsies from newly diagnosed diabetics have been
reported to express Fas and to contain apoptotic beta cells (Moriwaki et al.  1999).  As
mentioned before, CD8+ T-cells, suggested to have a critical role in the early stages
of beta cell destruction, may mediate apoptosis also through the perforin-granzyme
pathway, based on perforin-built channels on target cell membrane allowing
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granzyme entry and caspase activation (Kagi et al.  1994; Garcia-Sanz et al.  1987;
Yoon and Jun, 1999).
2.3. Nuclear pyknosis
Beside the well-known apoptotic and necrotic pathways, a pyknotic form of cell death
has also been distinguished. It morphologically resembles apoptosis with intact
plasma membrane, but is characterized by condensed but intact chromatin, unlike the
apoptotic fragmented DNA, demarcated at the margins of the nucleus (Tolskaya et al.
1995; Agol et al.  1998). Pyknotic morphology is typically seen in the early phase of a
cytocidal virus infection when the first virus-induced alterations in host cell
membrane organization and cytoskeleton have occurred (Koch and Koch, 1985). This
change is often irreversible and leads to lytic cell death. A comparable phenomenon
has also been observed during an apoptotic process, which due to a sudden ATP-
depletion or some other disability was interrupted and turned into secondary necrosis
(Hirsch et al.  1997; McCarthy et al.  1997).
3. Enteroviruses
3.1. Family of picornaviridae
Picornaviruses are a diverse group of small, non-enveloped animal viruses with
single-stranded RNA genome of positive polarity ('pico' Greek: very small - RNA
viruses) (Racaniello, 2001). The first infections, later pinpointed to have been caused
by a specific picornavirus, were described over 3000 years ago (poliomyelitis in a
temple record from Egypt ca. 1400 BC). Nowadays they comprise the most common
infections of humans in the developed world (Rotbart, 2002). Picornaviruses were
previously classified according to their physicochemical properties (particle density,
pH-sensitivity) and serological relatedness. More recently, the classification has been
based on nucleotide sequence comparisons. The picornavirus genera infecting man
include enteroviruses, hepatoviruses, kobuviruses, parechoviruses and rhinoviruses.
The enterovirus genus is further divided into five species, which are listed in Table 1
together with the previous subgroups (based on pathogenesis in experimental animals)
and serotypes (Hyypiä et al. 1997; King et al. 1999)
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Species Subgroups and serotypes
Poliovirus Polioviruses 1-3
Human enterovirus A Coxsackievirus A 2-8, 10, 12, 14, 16
Human enterovirus B Coxsackievirus A9
Coxsackievirus  B 1-6
Echovirus 1-7, 9, 11-21, 24-27, 29-33
Enterovirus  69
Human enterovirus C Coxsackievirus A 1, 11, 13, 15, 17-22, 24
Human enterovirus D Enterovirus  68, 70
Table 1. Species and subgroup division of enteroviruses
3.2. Enteroviral genome and viral replication cycle
In order to multiply, the virus must first bind to its specific receptor on the surface of
the target cell. Several receptors have been demonstrated for enteroviruses: coxsackie-
adenovirus receptor (CAR) is recognized by CVB 1-6 and decay-accelerating factor
(DAF, CD55) by CVB 1,3,5 (Bergelson et al.  1995; Bergelson et al.  1997; Bergelson
et al.  1998). In addition, CVA 9 has been shown to use alpha v beta 3 integrin, the
vitronectin receptor, to enter the host cells (Roivainen et al.  1994). In studies using
neutralizing antibodies, both alpha and beta cells in human islets were found to
express CAR (Chehadeh et al.  2000). After contacting the receptor, the virus should
successfully enter the cell, which commonly requires some conformational changes of
the viral capsid. During entry or immediately afterwards the viral genomic material is
released into the host’s cytoplasm in a process called uncoating. Once released in the
cytoplasm, the viral genomic RNA, about 7500 nucleotides in length, functions
directly as a template for the production of viral proteins. The single open reading
frame encodes a large precursor polyprotein. This precursor includes two proteolytic
sequences (2A and 3C), which cleave the precursor into intermediate products P1, P2
and P3 (Kitamura et al.  1981). P1 is further digested into capsid (structural) proteins
VP0, VP3 and VP1 (Korant, 1973). P2 and P3 are in the sequential steps cleaved into
seven non-structural proteins functioning in the replication and encapsidation of the
viral RNA and in the processing of the proteins. One specific product is the virus
RNA-dependent RNA polymerase (3D). It copies the genomic RNA into a negative-
sense strand, which then acts as a template for positive-strand RNA synthesis. Finally
the newly produced genomic material is packaged into the procapsids formed by
twelve pentameric structures, each of which contains five protomers (VP0-VP3-VP1
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–heterotrimers) (Korant, 1973). During this RNA-encapsidation, the VP0-protein is
further cleaved into VP2 and VP4 (maturation cleavage; relevant for enteroviruses,
but not for all picornaviruses (Hyypiä et al.  1992; Yamashita et al.  1998)) stabilizing
the procapsid.
Figure 2.  The replication cycle of enteroviruses.
3.3. Host response to virus infection
As suggested earlier, the outcome of an enterovirus infection may vary between
aggressive fulminant and acute subclinical (Ramsingh, 1997b; Yoon et al.  1979). In
suitable conditions persistence may develop (Chehadeh et al.  2000; Tam and
Messner, 1999; Klingel et al.  1992; Adachi et al.  1996; Conaldi et al.  1997a;
Conaldi et al.  1997b). In general, a viral invasion into an organism supplied with a
properly functioning immune system always attracts it to respond. The innate arm of
immunity composed of natural killer cells, natural (nonspecific) antibodies, the
complement system, phagocytes, antimicrobial peptides and interferons (IFNs)
together constitute the first line of defense. IFNs may mediate the antiviral response
through many routes. Firstly, through binding to type I IFN receptor (Platanias et al.
1996) they stimulate protein tyrosine kinases (JAK 1, TYK2) which further act to
stimulate STAT-, Crk- and IRS- pathways (Darnell et al.  1994; Uddin et al.  2000;
CVB
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Ahmad et al.  1997). These routes finally lead to the induction of anti-viral interferon
stimulated genes (ISG) (Bose and Banerjee, 2003). Interferons are also able to induce
the production of MHC-molecules on virus-infected cells and on antigen presenting
cells required for CD4+ T-cell action. Furthermore, they may initiate or contribute to
the production of antigen specific antibodies and thus activate the second line of
antiviral host defense, the adaptive or cell-mediated arm of immunity (Kadowaki et al.
2000). Recent observation in human islets concluded CVB-infection to stimulate INF-
α production selectively in beta cells, which by inhibiting the efficiency of viral
replication prevents the infection from disseminating and maintains it persistent
(Chehadeh et al.  2000). Furthermore, infection–induced IFN-α has been speculated
to participate in the initiation of beta cell autoimmunity (Chehadeh et al.  2000;
Chakrabarti et al.  1996; Stewart et al.  1993). It was recently observed that efforts of
the host to inhibit viral dissemination and persistence often involve induction of
apoptosis through either perforin-granzyme or death receptor mediated pathways
(Froelich et al.  1998; Ashkenazi and Dixit, 1998). IFNs are reported to sensitize
infected cells to apoptosis (Tanaka et al.  1998; Balachandran et al, 2000). When beta
cells are stimulated with IFNs in combination with double-stranded viral RNA or the
cytokine IL-1ß, a synergistic apoptotic effect is seen (Liu et al.  2002).
To defend themselves, many viruses have evolved to counteract the host responses.
To secure the replicative potential and production of progeny virions, it is favorable
for the virus to maintain the host cell viable and for this purpose many routes of the
host signaling machinery may be manipulated. For example, various steps of the IFN
cascade may be blocked by several different viruses (Ronco et al.  1998; Komatsu et
al.  2000; Katze, 1995; Munoz-Jordan JL et al.  2003). Also cleavage of p21(ras)
GTPase-activating protein (RasGAP) and activation of the MAPK family members
ERK 1/2, observed essential for CVB3 replication, could be affected (Opavsky et al.
2002; Huber et al.  1999a; Luo et al.  2002).
After stimulation of the innate arm of immunity a cell-mediated immune response is
launched. The dendritic cells, stimulated during the innate response by cytokines and
the pathogen itself, present antigen to naive T-cells, which start to develop differential
markers. Specifically the Th1 type CD4+ T-cells secrete proinflammatory cytokines,
which enhance virus-specific host cell lysis by CD8+ T-cells and stimulate the MCH-
upregulation on APC cells, which further helps in activating antibody production by
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B-cells. Other interleukines secreted by Th2 type CD4+ T-cells promote this B-cell
activation (Salusto et al. 1998).
The host responsiveness to virus and the outcome of the infection have been observed
to furthermore depend on the status of the host cell cycle. Several studies have
revealed actively dividing cells, like T-cells, to be more susceptible to virus and to
efficiently produce viral progeny (Molina et al.  1992; Liu et al.  2000b). Quiescent
cells (in G0 phase) on the other hand do not support viral multiplication, but may
harbor infective viruses thus creating persistence (Feuer et al.  2002). These theories
may partially explain the individual susceptibility of cells to infection. Some studies
further indicate several viruses capable of forcing the host cell into a favored phase of
cell cycle (Op De Beeck and Caillet-Fauquet, 1997; Swanton and Jones, 2001). Viral
mRNA, containing an internal ribosome entry site (IRES) instead of the eukaryotic 5'
cap, may also redirect the cellular translation pattern and favor viral protein synthesis,
particularly in enterovirus-infected cells where cap-dependent translation is
specifically inhibited (Kuyumcu-Martinez et al.  2002; Marissen et al.  2000).
3.4. Infections and clinical manifestations
Enteroviruses are predominantly transmitted by the fecal-oral route into the human
body, although transmission via either upper respiratory tract or the conjunctiva of the
eye is also possible. They normally replicate in the respiratory and gastrointestinal
mucosa, where the infection may remain subclinical or result in mild symptoms. In a
proportion of cases, the virus spreads through the lymphatics into the circulation, and
after a brief viraemic phase may establish secondary replication sites in specific
tissues and organs. Polioviruses may proverbially enter the central nervous system,
replicate in the motor neurons and in about 1% of cases with the most virulent strains
result in flaccid paralysis (Melnick, 1996). Coxsackie A viruses typically induce
diseases with mucosal and skin lesions (e.g. herpangina, hand, foot, and mouth
disease) (Itagaki et al.  1983; Seddon and Duff, 1971; Bendig and Fleming, 1996). In
addition to the milder disorders, coxsackie B viruses are also associated with more
severe and possibly chronic diseases including meningitis, myopericarditis, epidemic
pleurodynia and T1D (Gauntt and Huber, 2003; Beck et al.  1990; Muir and van Loon,
1997; Rotbart, 1995; Tracy et al.  2000). They are together with echoviruses
responsible for severe neonatal viral infections (Chiou et al.  1998; Sawyer, 1999).
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3.5. Enteroviruses and T1D
Enterovirus infections could initiate or accelerate beta cell damage many years before
the clinical onset of T1D. Seroepidemiological studies exist to support this at least
after early CVB and rubella exposures (Hyöty et al.  1995; Lönnrot et al.  1998;
Lönnrot et al.  2000, Salminen et al, 2003). Some small case-control reports show
evidence for intrauterine viral exposure, a maternal enterovirus infection, as a risk
factor for future development of T1D (Dahlquist et al.  1995, Hyöty et al.  1995). In a
larger birth cohort study (Viskari et al.  2002) and in another, particularly CVB-
directed, smaller study (Fuchtenbusch et al.  2001) though contradictory results were
obtained. A recent survey reveals that while the incidence of T1D has doubled within
the last 40 years in Finland, the incidence of enterovirus infections has simultaneously
decreased (Karvonen et al.  1999; Viskari et al.  2002). Also the maternal enterovirus
antibody levels have decreased (Viskari et al.  2002). The low maternal antibody
status could boost the viral exposure of the fetus/newborn and the rarer incidence
furthermore exposes the child to catch the infection later, often in the absence of
protecting maternal antibodies (Viskari et al.  2000). This phenomenon could partially
explain the increasing number of type I diabetics and supports the role of
enteroviruses as possible triggers. Coxsackie B viruses have long been associated with
the pathogenesis of T1D (Andreoletti et al.  1997; Banatvala et al.  1985; Yoon,
1990). Groundbreaking findings were made in 1979 (Yoon et al.) when the autopsy
specimens of a 10-year-old diabetic showed lymphocytic infiltration of the islets and
beta cell necrosis which lead to the detection of a diabetogenic variant of CVB-4 from
the pancreatic cultures (Yoon et al.  1979). This very serotype was further observed to
induce T1D in mouse. However, in a series of 88 pancreas-specimens from patients
who died soon after onset of T1D, coxsackieviruses were not detected in the islets
(Foulis et al. 1990). Therefore, it should be considered unlikely that an acute CVB
infection in pancreatic islets would frequently associate with the onset of T1D.
However, this does not exclude the possibility that CVB could have been present in
the islets at an earlier stage of T1D pathogenesis. In recent seroepidemiological
studies several enterovirus serotypes have been shown to share the association with
T1D (Frisk et al.  1992; Helfand et al.  1995; Roivainen et al.  1998; Otonkoski et al.
2000; Vreugdenhil et al.  2000). In fact, it has been proposed that any serotype could
potentially possess diabetogenicity. Furthermore, aggressive, cytolytic isolates can
develop from originally benign enterovirus serotypes (Roivainen et al.  2002).
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3.6. Mechanisms of beta cell destruction
T1D is an immune-mediated disease in which a specific immune response to islet beta
cells is induced. In the animal model of T1D, the NOD mouse, diabetes may be
transferred only with cells of the immune system. Also in humans T1D has been
adoptively transferred via bone-marrow transplantation from a diabetic donor.
However, there are several mechanisms through which a virus could induce immune-
mediated destruction of islet beta cells, as shown in figure 3 beneath.
Figure 3. The putative pathways involved in virus induced beta cell death.
A potential course of the process: Virus infects the beta cell and stimulates
intracellular IFNα/ ß and MHC I production and the innate arm (IFN, non-
specific antibodies and NK cells) of the hosting immune system. The
resulting initial beta cell damage provokes the activation and infiltration of
macrophages and T cells, which secrete cytokines and finally stimulate
antibody production. The produced cytokines, interferons, nitric oxide, ROS
and perforin contribute to beta cell death through apoptosis or necrosis.
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3.6.1. Lysis
Lytic cell death is an aggressive, rapid process featured by breakdown of the cell's
structural integrity. It equals necrosis, which is used generally to describe cell death of
aggressive nature. As mentioned earlier viruses often induce host cell pyknosis in the
initial phase of infection (Koch and Koch, 1985), which may in later stages turn into
lysis. In a recent study (Roivainen et al.  2002) a large group of prototype
enteroviruses from different genetic subgroups were characterized according to their
cytolytic activity. Echovirus 6, 7, 11, CVA 13, CVB 1, 3, 4, 5, 6 and poliovirus type
1/Mahoney were detected to cause beta cell lysis. Furthermore an echovirus 9 isolate,
from a 6-week-old baby with acute onset T1D was found with destructive features
unlike its corresponding prototype virus. These variations of outcomes might have to
do with donor-related characteristics, thus the possibility that a certain HLA-type or
antibody-positivity could confer resistance or susceptibility for destructive beta cell
death remains.
3.6.2 Apoptosis
In order to maintain an efficient multiplication environment, viruses may prevent or
delay host cell death through various routes. Especially the abilities to block p53
tumor suppressor -dependent and Bax/Bak/Bik -dependent apoptosis are well
characterized (Bargonetti et al.  1992; Dobner et al.  1996; Scheffner et al.  1993;
Chen et al.  1996; Afonso et al.  1996; Henderson et al.  1993). On the other hand the
same pathways may be used in the opposite direction to induce host cell apoptosis and
safely release new viral particles in enveloped bodies to be engulfed by other target
cells (Debbas and White, 1993; Sastry et al.  1996; Westendorp et al.  1995).
Additionally, by this mechanism the inflammatory/immune reactions following lytic
cell death or free virus exposure are avoided and contact with neutralizing antibodies
is prevented, thus potentiating the survival of the virus and uninterrupted
dissemination of infection (Jeurissen et al.  1992; Gliedman et al.  1975). Concerning
non-enveloped viruses, into which category enteroviruses belong, the mechanisms of
exit from a dying host cell are still unknown. Although cell lysis is thought to play a
major role, a recent report presents host cell apoptosis as a potential new explanation.
It would result in formation of membrane-bound bodies enabling viral exit (Teodoro
and Branton, 1997). In the group of picornaviruses, apoptosis has been extensively
studied by the model of CVB3 induced myocarditis, during which persistence often
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develops and apoptotic myocardial death is evident (Carthy et al.  1998; Huber et al.
1999b). Also poliovirus infection or individual poliovirus proteases alone are reported
to be able to induce apoptotic death in selected cell types (Lopez-Guerrero et al.
2000; Goldstaub et al.  2000; Barco et al.  2000; Girard et al.  1999; Tolskaya et al.
1995).
Considering development of T1D, virus infections are regarded as the leading
environmental triggers and apoptosis the leading form of beta cell death (Eizirik and
Mandrup-Poulsen, 2001). Their possible association is difficult to study in clinical
materials. Experimentally, recent studies on rat islets stressed with synthetic double
stranded RNA, a general product of viral replication, reveal enhanced susceptibility to
cytokine induced islet cell apoptosis by Fas-FasL interaction (Liu et al.  2002). Virus
infections generally induce an inflammatory reaction mediated in part by
proinflammatory cytokines. In addition to their direct proapoptotic potential,
cytokines may also launch the expression of MHC class I molecules in beta cells
followed by their appearance on plasma membranes, which exposes beta cells to T-
cell mediated death through Fas or perforin dependent pathways (Kim et al.  2002;
Seewaldt et al.  2000).
3.7. Enteroviruses as triggers of autoimmunity in T1D
3.7.1. Molecular mimicry
Molecular mimicry is based on a sequential and structural homology between a
foreign antigen and a host protein enabling an immunologic attack against the
pathogen to cross-react with the host molecule (Davies, 1997). Glutamic acid
decarboxylase GAD65, an enzyme synthesizing the inhibitory neurotransmitter gamma
amino butyric acid (GABA), is one of the important islet cell autoantigens in T1D. In
1992 the sequences of GAD65 and the non-structural protein 2C of CVB-like
enteroviruses were shown to share a similar motif (PEVKEK) and to bind the same
groove in a MHC-molecule in an exactly similar position (Kaufman et al.  1992). In
later studies with synthetic peptides, the binding was restricted to HLA-DR3 molecule
(Vreugdenhil et al.  1998). Furthermore, GAD65-reactive T-cells are present and
circulating in both T1D patients and healthy normal people, with the difference of
functioning like pre-activated memory cells in patients and thus being highly more
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susceptible to enter clonal expansion. These data have given evidence for molecular
mimicry between enteroviral and self-factors as a possible mechanism of beta cell
destruction, although contradictory observations have also been made (Schloot et al.
2001; Horwitz et al.  1998; Marttila et al.  2001; Atkinson and Maclaren, 1994).
Accordingly, molecular mimicry could also exist between GAD and cytomegalovirus
on T-cell level (Roep et al.  2002).
3.7.2. Local inflammatory damage and bystander activation
The model of locally (intra-pancreatically) launched beta cell autoimmunity and
destruction has been widely studied by Horwitz et al. (1999). Their recent report
concluded that the primary role of an enterovirus infection (pancreatrophic CVB4) in
the pathogenesis of T1D is to specifically infect and damage beta cells leading to
release of sequestered islet antigen and stimulation of a local inflammatory response.
The intra-pancreatic antigen presenting cells introduce the antigen to the population of
resting beta-cell-autoreactive T-cells resulting in initiation of the disease process.
Unless a critical threshold level of these precursor autoreactive T-cells exist, the
destructive process will not be triggered (Horwitz et al.  1998). They also observed
the critical role of beta cell damage as the driving force of virus induced T1D, since a
non-specific cytokine-attack did not precipitate T1D in mice with a diabetogenic T-
cell repertoire, while exposure to the beta-cell toxin streptozotozin was able to do it
(Horwitz et al.  2002). CVB infections have previously been reported to lead to
necrotic cell death in both rodent and human exocrine pancreatic tissue (Lansdown,
1976; Vella et al.  1992; Arnesjo et al.  1976; Ozsvar et al.  1992; Ramsingh, 1997a).
The inflammatory mediators produced during this infective process have been
speculated to activate the bystanding beta-cell-autoreactive T-cell pool and thus
possibly accelerate T1D development (Serreze et al.  2000).
4. Oxidative stress
4.1. Oxidative metabolites and cell death
Oxygen derived reactive metabolites (reactive oxygen species, ROS) appear
abundantly in the human body. They form as a consequence of incomplete reduction
of molecular oxygen by the mitochondrial respiratory (electron-transport) chain
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(Fernandez-Checa et al.  1998) or through some reactions of cellular metabolism by
oxidizing enzymes including xanthine oxidase, P450 mono-oxygenase, cyclo-
oxygenase, lipoxygenase, monoamine oxidase etc (Forman, 1982; Boveris and
Chance, 1973; Maeda et al.  1999; Siraki et al.  2002). The most common intracellular
ROS molecules include superoxide anion (O2
-), hydrogen peroxide (H2O2) and
hydroxyl radical (-OH) (Fridovich, 1998; DiGuiseppi and Fridovich, 1984).  ROS
react with biological molecules such as proteins, lipids, carbohydrates and DNA
threatening their integrity and exposing the organism to toxic, mutagenic and
carcinogenic assaults (Stadtman and Levine, 2000; Steinberg, 1997; Marnett, 2000).
Small GTPases Ras and Rac1, for example, have been shown to be ROS targets
leading to altered signal transduction (Sundaresan et al.  1996; Irani et al.  1997).
Except for -OH, which is mostly noxious, ROS also have beneficial functions mainly
as stimulators and mediators of intracellular signaling cascades (Ohba et al.  1994; Lo
and Cruz, 1995; Krieger-Brauer and Kather, 1992; Sundaresan et al.  1995). They also
function in microbial killing during infection, for example through inactivating viral
enzymes by nitrosylation (Colasanti et al.  1999; Babior, 1978a; Babior, 1978b;
Adams et al.  1990). Their properties often shift into pathologic in response to
increasing concentrations, which might be due to the metabolic state (Di Meo and
Venditti, 2001; Gambelunghe et al.  2001), pH, oxygen partial pressure (pO2) and
ADP availability. Very commonly overproduction of ROS is triggered by non-
physiological states like inflammation or exogenous toxins, which stimulate
phagocytic cells to produce ROS. In a variety of disease processes associated with
either acute or chronic inflammation, increased oxidative stress appears to be
involved. Depending on the surrounding milieu, ROS molecules may also react
together. Specifically, in a reaction between O2
- and NO highly cytotoxic
peroxynitrite, ONOO- is formed (Beckman and Koppenol, 1996), which may further
react with carbon dioxide (CO2) to form peroxocarboxylate (ONOOCO2
-). H2O2 may
react with H+ + Cl- or Cu+/Fe2+ forming either highly reactive HOCl (hypochlorus
acid) or a hydroxyl radical, respectively (Babior 2000).
Highlighting the dual role of ROS in both physiological and disease states, recent data
show concentration dependent stimulation of either cell growth or death. Moderate
levels of pro-oxidants may promote mitogenic stimuli (Burdon and Rice-Evans, 1989)
e.g. by affecting kinase or proto-oncogene activities (Larsson and Cerutti, 1988;
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Cerutti and Trump, 1991). At slightly increased levels ROS are reported at various
different experimental conditions to be able to induce apoptotic cell death either
directly or in combination with antioxidant, mainly glutathione (GSH), depletion
(Hampton and Orrenius, 1997; Macho et al.  1997; Lennon et al.  1991). The
stimulatory mechanisms often involve exposing to or triggering the mitochondrial
membrane permeability transition which leads to the release of apoptogenic factors
and thus stimulation of the downstream apoptotic cascade (Petronilli et al.  1994;
Costantini et al.  1996; Fleury et al.  2002; Ueda et al.  2002; Wei and Lee, 2002;
Armstrong and Jones, 2002; Dypbukt et al.  1994; Datta et al.  2002; Armstrong et al.
2002). Also, HIV-infection mediated apoptosis of CD4+ T-cells is preceded by ROS-
production and antioxidant depletion. This process has recently been associated with
p53, NF-κB and AP-1, pro-apoptotic redox-active factors, that also support
expression of viral genes and pro-inflammatory cytokines (Perl et al.  2002). p53,
independent of the activating factor, may further stimulate ROS production and
induce apoptosis (Sawada et al.  2001; Li et al.  1999).
Moreover, studies evidencing antioxidants' capacity to inhibit apoptosis and recent
observations on antiapoptotic molecules with antioxidative properties further argue
for a role for ROS in stimulating apoptosis (Melnick, 1996; Kelso et al.  2001; Sato et
al.  2002). Additionally, oxidants may direct an apoptotic process into a necrotic one
by inactivating caspases or impairing the mitochondrial energy production resulting in
subsequent ATP depletion (Samali et al.  1999; Leist et al.  1999). Although possible
in the other direction, overwhelming oxidative stress usually always leads to necrosis
leaving no possibilities to inhibit or re-regulate the process towards apoptosis.
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4.2. Antioxidative machinery
In an attempt to prevent ROS-mediated damage, cells have developed an antioxidative
defense system (Benzie, 2000). The main goal is to maintain the intracellular milieu
in a reduced and stable state. This antioxidative machinery consists of several
components including heme- or thiol-based enzymatic systems and non-enzymatic
scavengers. The most ubiquitous and abundant of them is the glutathione (GSH)
system (Deneke and Fanburg, 1989; Anderson, 1998). GSH is formed from the
aminoacids glutamate, cysteine and glycine in two ATP-dependent enzymatic
reactions by gamma-glutamylcysteine synthetase and glutathione synthetase (Griffith
and Mulcahy, 1999). GSH itself functions mainly as a sulfhydryl buffer and helps to
detoxify xenobiotics in conjugation reactions catalyzed by glutathione S-transferase.
Most importantly glutathione peroxidases, selenocysteine-containing enzymes, use
GSH as substrate in the elimination of e.g. hydroxyl radical, peroxynitrite,
hydroperoxides and reactive electrophiles. In these reactions two GSH-molecules are
oxidized to GSSG, which is converted back to reduced GSH in an NADPH-dependent
reaction either by glutathione reductase or the thioredoxin system, described below.
Furthermore, as a thiol-containing reductant, GSH maintains so-called thiol-enzymes
in their catalytically active forms, and low molecular weight antioxidants, vitamins C
and E in their biologically active forms (Fridovich, 1999).
Other major antioxidants include catalase (CAT) and superoxide dismutase (SOD).
As referred to by its name, the latter inhibits ROS-mediated damage by scavenging
O2
- (Fridovich, 1995; Fridovich, 1999) Two isoenzymes exist: an essential
mitochondrial Mn-SOD and a less essential cytosolic Cu/Zn-SOD. They metabolize
two O2
- molecules to O2 and H2O2; thus another ROS is formed. The general and
ubiquitous mechanism to remove H2O2 is by peroxisomal heme-containing CAT,
which converts two H2O2 molecules to O2 and 2 x H2O (Kirkman and Gaetani, 1984;
Kirkman et al.  1999). Moreover, CAT detoxifies e.g. phenols and alcohols via
coupled reactions with H2O2.
Another thiol-containing and ubiquitous reducing enzyme system is the thioredoxin
(Trx) machinery. Trx functions as a hydrogen donor for other catalytic enzymes (e.g.
glutathione peroxidase) and reduces disulfide bonds of diverse proteins (Holmgren,
1984). It protects particularly against peroxide induced stress (Spector et al.  1988;
Nakamura et al.  1994) and has also been reported to have anti-apoptotic power
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(Saitoh et al.  1998). Like the GSH system, oxidized Trx is converted back to reduced
form by a flavoenzyme thioredoxin reductase (TrxR) in an NADPH-dependent
reaction (Holmgren, 1985). In addition to Trx, TrxR reduces lipid peroxides, diverse
antioxidative selenium containing compounds and converts vitamin C back to its
active reduced form.
A distinct, non-enzymatic group of antioxidants of low molecular weight include
vitamins E and C, several selenium-containing compounds, lipoic acid, and
ubiquinones. Ascorbic acid (AA; vitamin C) and alpha-tocopherol (alpha-TOH;
vitamin E) constitute the major water-soluble and lipid-soluble small antioxidants,
respectively (Buettner, 1993). As alpha-TOH reduces e.g. peroxyl radicals by its OH-
group and converts into tocopheroxyl (chromanoxyl) radical, vitamin C, as its main
function, reduces it back to alpha-TOH, the active vitamin E (Sies et al.  1992).
Additionally, vitamin C acts as an electron donor for some transmembrane enzymes
with oxidoreductase activity (May et al.  1995). As previously mentioned, TrxR
reduces oxidized vitamin C (Mendiratta et al.  1998), but its major recycler is GSH
(May et al.  1996).
Heme (Fe protoporphyrin IX) is an integral protein to life as delivering oxygen into
cells. It circulates incorporated in hemoproteins and occurs unbound (free) only in
pathologies sometimes associated with tissue accumulation. Free heme as such is a
powerful oxidative molecule and thus a system for its degradation exists. It consists of
an oxidative stress–inducible protein HO-1 (heme oxygenase-1, HSP32) and the
constitutive isozyme HO-2, which catalyze the oxidation of heme to biologically
active molecules: free iron, a gene regulator (Ferris et al.  1999), biliverdin, an
antioxidant and carbon monoxide, a heme ligand (Maines, 1997).
Uric acid is produced in liver and represents the end product of the purine metabolism
reaction chain. The enzyme xanthine oxidase catalyses the last two reactions from
hypoxanthine through xanthine to uric acid as byproducts of which two molecules of
H2O2 are created. Uric acid is considered a powerful antioxidant (Ames et al.  1981)
especially because of its potency in peroxynitrite scavenging (Balavoine and Geletii,
1999; Regoli and Winston, 1999; Whiteman et al.  2002) but also in its ability to
chelate transition metal ions and stabilize reactive hypochlorus acid and hydroxyl
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radical (Becker, 1993). On the other hand, its increased production indicates increased
H2O2 production, which may further react with peroxynitrite and form new aggressive
oxidative metabolites (Skinner et al.  1998; Vasquez-Vivar et al.  1996; Santos et al.
1999) including alloxan and a nitrite derivative capable of NO release. These both are
known for their direct or indirect beta cell toxicity (Lenzen and Panten, 1988). NO
may further stimulate peroxynitrate production by reacting with superoxide, thus
contributing to beta cell injury (Suarez-Pinzon et al.  1997; Suarez-Pinzon et al.
2001). However, there is evidence that uric acid might further react with and scavenge
also these newly formed radicals (Whiteman and Halliwell, 1996; Kooy et al.  1994),
which implies to a dual role for this molecule in controlling/affecting the cellular
redox status.
4.3. Redox status in beta cells and T1D
Cellular damage in diabetes is most probably associated with various biochemical
pathways. There is evidence that oxidative mechanisms participate in the
pathogenesis of both beta cell destruction at the prediabetic period and of vascular
damage and endothelial dysfunction during the development of further disease
complications. According to recent knowledge, the latter are mostly due to increased
mitochondrial production of superoxide anion stimulated by prolonged hyperglycemia
(Nishikawa et al.  2000). The earlier mentioned NF-κB, an important mediator of
cytokine induced pathways of beta cell damage, is also redox-sensitive and assumably
also activated by the minor amounts of ROS produced at the initial stage of beta cell
destruction. NF-κB is further reported to increase the expression level of iNOS
(among other genes) and then through NO-signaling to downregulate the expression
levels of beta cell specific genes including Pdx-1, Glut-2, and Isl-1 and also to
stimulate the production of cytokines and chemotactic agents amplifying the
production of ROS. This cascade then leads to beta cell dysfunction and death through
apoptosis or necrosis depending on the overall stress (Cardozo et al.  2001; Ho and
Bray, 1999). A chain of events resembling this is also considered to characterize
insulitis, during which T-cells and macrophages invade the islets and act as sources of
inflammatory mediators and ROS (Rabinovitch et al.  1996b).
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Many studies have discovered the general antioxidative capacity to be defective in
diabetic patients (Santini et al.  1997; Maxwell et al.  1997; Tsai et al.  1994).
Depending on the design of the study, decreased levels of vitamin C, vitamin E, uric
acid, GSH and GSH-related enzymes have been detected in diabetics compared to
control subjects (Maxwell et al.  1997; Marra et al.  2002; Seghieri et al.  1998;
Courderot-Masuyer et al.  2000; Jain and McVie, 1994; Ruiz et al.  1999;
Seghrouchni et al.  2002; Sharma et al.  2000; Hoeldtke et al.  2002). Controversial
results also exist and imply the need for critical evaluation of the markers measured to
assess oxidative stress (VanderJagt et al.  2001; Leinonen et al.  1998; Vessby et al.
2002).  Importantly, beta cells themselves have a poorer antioxidative defense system
in comparison to other cell types. In specific, the expression levels and activities of
antioxidants are low and the adaptive properties to increase antioxidant enzyme
production during stress are limited, thus rendering beta cells extremely vulnerable to
oxidative damage (Grankvist et al.  1981; Lenzen et al.  1996; Tiedge et al.  1997).
Further evidence for these defects have been obtained from substitution studies on
insulin producing cells showing effective protection against ROS- or cytokine-
mediated cell death by a cocktail of antioxidants CAT+Gpx+SOD (Tiedge et al.
1998; Lortz et al.  2000). Beta cells' own properties are also considered to affect their
survival, exemplified by exaggerated ROS-sensitivity during low glucose levels and
slow mitochondrial metabolic rate. Thus, normal kinetics of glucose metabolism may
protect beta cells against ROS-induced damage (Pipeleers et al.  2001).
The role of Trx has been studied in nonobese diabetic mice overexpressing Trx
specifically in beta cells. The incidences of both spontaneous autoimmune and drug-
(streptozotocin, a ROS generating agent) induced T1D were reduced (Hotta et al.
1998). Also after major injury (partial pancreatectomy) or transplantation,
antioxidative molecules have been shown to increase beta-cell survival through e.g.
attenuated apoptotic beta cell death and increased viability (Ribeiro et al.  2003;
Laybutt et al.  2002; Bottino et al.  2002; Gunther et al.  2002; Pileggi et al.  2001).
Overall, the existing data indicates oxidative molecules to be important mediators of
beta cell damage and thus suggests a role for antioxidant supplementation in diabetes.
Due to the complexity and non-specificity of the machinery controlling redox status,
this balance is of crucial importance.
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5. Virus infections and oxidative stress: Interactions
Malnutrition is known to result in defective and inefficient antioxidative capacity and
aggravated exposure to oxidative stress triggered by various pathogens, e.g. viruses
(Sofic et al.  2002). According to the traditional view, malnutrition could predispose
an individual to infections by weakening the host's immune system and thus allowing
the pathogen to multiply and disseminate in the organism. Today it is generally
known that many virus infections (e.g. influenzavirus induced pneumonia, HIV,
coxsackievirus myocarditis) exert many kinds of oxidative stress in the host (Schwarz,
1996; Xie et al.  2002b; Maeda and Akaike, 1998). Phagocytes become activated and
produce ROS (Peterhans et al.  1987) and pro-oxidative cytokines (TNF-α, IL-1β),
which further potentiate oxidative and other viral damage through e.g. increased virus
multiplication, impaired mitochondrial function and reactive iron accumulation (Polla
et al.  1996; Schulze-Osthoff et al.  1992; Schreck et al.  1992; Klempner et al.  1978).
Various studies have demonstrated the effect of these cytokines to provoke ROS,
especially NO, production within the islets, both in macrophages and beta cells
(Rabinovitch and Suarez-Pinzon, 1998; Eizirik et al.  1996; Rabinovitch et al.  1996a;
Mandrup-Poulsen et al.  1990). Similarly, the pathogenesis of influenza virus induced
pneumonia has been reported to be mostly due to IFN-γ mediated NOS and iNOS
activation resulting in NO and further peroxynitrate production (Akaike et al.  1996).
The previously mentioned antioxidant-substitution studies confirm ROS production to
mediate IL-1β + TNF-α + IFN-γ stimulated beta cell damage (Lortz et al.  2000).
These interactions are further strengthened by the knowledge of NF-κB as a mediator
of both ROS and cytokine induced apoptosis and the fact that also ROS mediate p53-
dependent apoptosis, the pathway commonly used by viruses (Datta et al.  2002;
Armstrong et al.  2002).
The exposure to radical stress is further intensified by virus-mediated impairment of
host's antioxidative defenses through decreasing concentrations of several ROS
scavengers (Xie et al.  2002a; Hennet et al.  1992; Bannister et al.  1986; Staal et al.
1992; Allard et al.  1998). Many in vitro studies have characterized this phenomenon
and observed reparative effects by supplementing antioxidants. In vivo the effect of
antioxidant therapy is usually tested as a supplement to some specific antiviral
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treatment, because of the antioxidants weak efficiency alone. In some combinations,
antioxidative supplement has resulted in improved outcome of the specific therapy for
influenzavirus and HIV infections, although the specific mechanisms of protection
still remain poorly understood (Allard et al.  1998; Oda et al.  1989). Concerning the
immune system, ROS may act as immunomodulators allowing or activating T-cell
proliferation, an essential phenomenon in cell-mediated immune response. This idea
is based on observations on the ability of several antioxidants to directly inhibit T-cell
proliferation or the activation of transcription factors involved in T-cell activation
(Hunt N, 1994; Chaudhri et al.  1986). On the other hand, the fatality of HIV infection
lies on the exact opposite: increased apoptosis of CD4+ T-cells potentiated or
possibly even triggered by the changed redox status (Romero-Alvira and Roche,
1998; Banki et al.  1998).
Only recently it has been shown that the interactions extend further. Malnutrition and
deficiency of antioxidants are capable of affecting not only the host, but also the
pathogen by increasing its virulence. In a series of experiments Beck et al. first
observed that an avirulent strain of CVB3 (3/0), which did not cause any damage in
normally fed control mice, established moderate myocardial lesions in both selenium
or vitamin E deficient mice. When this avirulent strain was further passaged in a
selenium or vitamin E deficient mouse and then reinoculated into a control mouse,
severe myocardial damage was provoked. This was shown to be due to six point
mutations in the viral genome, which changed an originally avirulent strain into
virulent (Beck, 1997). As an example of another virus, ROS are reported to activate
the binding of NF-κB to the viral promoter region of HIV resulting in increased viral
replication and production of Tax protein. Tax again stimulates NF-κB (Baruchel and
Wainberg, 1992) thus creating a vicious cycle for the benefit of the dissemination of
the infection.
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AIMS OF THE STUDY
The specific aims were
• To investigate the mechanisms of coxsackievirus mediated beta cell death
during productive and restricted infective conditions
• To compare the mechanisms of beta cell death during low versus high
multiplicity of coxsackievirus infection
• To study the effects of low versus high multiplicity infection on intracellular
thiol balance in beta cells
• To elucidate the mechanisms of oxidative beta cell damage and to improve the
defense of beta cells against reactive oxygen species by manipulating their
thiol supply
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GENERAL METHODOLOGY
More detailed protocols of all methods used are provided in the original publications.
1. Cell and tissue culture
1.1. Human islets  (I, IV)
Isolated and purified human islets were obtained from Uppsala, Sweden (Nordic
Network for Clinical Islet Transplantation, Department of Clinical Immunology and
Transfusion Medicine) and Brussels, Belgium (Central Unit of ß-Cell Transplant). All
processes followed the protocols approved by local ethics committees (Brandhorst et
al.  1998; Ricordi et al.  1988). The cells were sent to Helsinki as free floating islets
and further cultured on petri dishes in Ham's F-10 nutrient mixture with supplements.
The volume and purity of the islets were determined under light microscope after
staining with diphenylthiocarbazone, and only preparations of over 50% purity were
selected for experiments.
1.2. Fetal porcine islets  (III)
Yorkshire sows, 80 to 95 days pregnant, were obtained from a breeding piggery and
killed with high voltage electrical stunning and immediate exsanguination at the
slaughterhouse of the Department of Food Technology, University of Helsinki. The
fetuses (crown-rump length 21-25 cm) were collected immediately, transported to the
laboratory where the pancreases were aseptically removed within two hours after
killing and prepared for culture as previously described (Korbutt et al.  1996;
Otonkoski et al.  1999). This fetal porcine model was verified suitable for studies
considering enterovirus infections in beta cells (Roivainen et al. 2001).
1.3. Insulin producing cell lines  (II, IV)
INS-1 is a rat tumor-derived relatively differentiated insulin-producing cell-line,
which has been shown to be suitable for the study of beta cell biology (Asfari et al.
1992). RINm5F is a less differentiated rat insulinoma cell line. These lines were
kindly provided by Prof. Claes Wollheim (University of Geneva, Switzerland).
MIN6 is a more novel insulinoma cell line of mouse origin. It possesses better
functionality defined by closer resemblance to the physiological characteristics of
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primary beta cells including better insulin secretory response to glucose and higher
intracellular insulin content (Poitout et al.  1996; Ishihara et al.  1993). Thus, it
represents a more sophisticated model for studies of beta cell biology in vitro.
2. Enterovirus infections
2.1. Viruses  (I, III, IV)
Prototype strains of CVB3/Nancy, CVB4/J.V.B., CVB5/Faulkner and CVA9/Griggs
(from the American Type Culture Collection, Manassas VA) and the diabetogenic
strain CVB4-E2 (from Dr. JW Yoon) were used in the experiments. All virus stocks
were passaged in GMK (green monkey kidney) cells and their identities were
confirmed by plaque-neutralization assays.
2.2. Viral exposure and infectivity measurements  (I, III, IV)
Dilutions of virus preparations corresponding to certain multiplicities were prepared
and the cells were exposed to them for 60 minutes at 36°C. The adsorption was
followed by removal of the inoculum virus and addition of cell-preparation-specific
culture medium. The cultures were incubated in CO2-athmosphere at 36°C and the
culture medium was changed twice a week.
Cell samples were collected after 0 hours, 1, 2 and 3 days of infection. For
measurements of total infectivity the samples were frozen and thawed three times to
release the virus followed by centrifugation and analysis of the supernatant in a
dilution series on GMK cells. To visualize the infected cells, immunocytochemistry
for enterovirus antibody was performed for methanol-fixed cells. A sample of non-
infected cells served as a negative control. The result was analyzed by confocal
microscopy showing infected cells in green.
2.3. Antiviral agents  (III)
Restricted infective conditions were created by addition of a selective inhibitor of
viral RNA replication into the culture medium immediately after exposure to the
virus. In low concentrations (0.1-2 mM) the used inhibitor, guanidine hydrochloride,
functions strictly anti-virally against small, unenveloped, RNA containing viruses,
like coxsackieviruses (Pfister and Wimmer, 1999; Bovee et al.  1998). We tested its
potential in 0.1 mM, 0.5 mM and 1 mM concentrations.
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3. Oxidative stress
3.1. Oxidants and antioxidants  (II)
We used hydrogen peroxide (H2O2) to establish oxidative conditions. H2O2 was
chosen instead of known beta cell specific toxins (e.g. alloxan and streptozotocin)
because of its presence in physiological oxidative processes. We tested 50 µM and
100 µM concentrations, to which INS-1 cells were exposed for 60 min at 37°C
followed by a 24-hour incubation in culture medium.
Thiols are efficient reducing molecules that protect cells by interacting with free
reactive radicals. Glutathione (GSH) system represents the most important part of the
intracellular anti-oxidative machinery. L-cysteine is the precursor of GSH and thus
necessary for its synthesis. L-cysteine was chosen instead of the frequently used N-
acetylcysteine (NAC) because the deacetylation reaction needed for NAC to enter the
intracellular space may not be operative in cell culture models. We tested the ability
of 0.1 mM, 1 mM and 5 mM concentrations of L-cysteine to protect the cells from
H2O2 induced damage. The exposure was similar and simultaneous with the H2O2
treatment.
3.2. Thiol analysis  (II, IV)
Samples of RINm5F cells were analyzed straight after H2O2 and/or L-cysteine
treatments for the level of intracellular GSH-content by a spectrofluorometric method.
The samples were first exposed to 15 mM monobromobimane in 50 mM N-
ethylmorpholine terminated by 100% trichloroacetic acid after 5 min. After quick
centrifugation one µl of supernatant was injected onto a Waters Novapak C-18 HPLC
column running an isocratic mobile phase (acetonitrile, acetic acid, perchloric acid,
pH 3.7). The fluorescent product was detected using Shimadzu RF-10AxL
spectrofluorometer with excitation and emission wavelengths at 394 nm and 480 nm
(Ahola et al. 1999). Instead, from samples of virus-exposed MIN6 cells the infectivity
was first abolished by acidic-treatments after which the same protocol was followed
for GSH-measurements.
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3.3. Northern blot analysis for gamma-glutamyl cysteine synthetase gene
expression (IV)
8 µg of DNase treated total RNA extracted by a commercial kit (RNAeasy, Qiagen)
was analyzed by northern blot to detect the level of γ-glutamylcysteine synthetase
during a CVB5 infection of low versus high multiplicity at timepoints of one and four
days. First the RNA samples were transferred onto nylon membranes and the blots
were then hybridized with 32P-labelled (DuPont) complementary RNA probe
corresponding to nt 874-1106 of the published sequence (Lu et al. 1992). Finally, the
membranes were rinsed, exposed to autoradiography films, stripped and reprobed
with 32P-labelled 18S RNA probe to normalize mRNA loading. The result was
densitometrically analyzed as a ratio to the loading control.
4. Detection of the mechanisms of cell death
4.1. Nuclear stainings  (I, II, III, IV)
A fluorescent nuclear staining was performed to measure viability and score the
mechanistic pattern of cell death. The analysis is based on double staining with
Hoechst 33342 (HO) and ethidium homodimer-1 (EthD-1). HO stains all nuclear
DNA blue. Instead, EthD-1 only permeates damaged cellular membranes (necrotic
cells and late-phase apoptotic cells) and stains DNA red. Viable, pyknotic and
necrotic cells are identified by round nuclei with either homogenous blue, bright
condensed blue or homogenous red fluorescence, respectively. Apoptotic cells are
detected by their fragmented nuclei that exhibit either blue or red fluorescence
depending on the stage of the process (Hoorens et al.  1996).
Nuclear DNA fragmentation was further analyzed by TUNEL-staining (terminal
dideoxynucleotidetransferase mediated dig-ddUTP nick end labeling). It was
combined to cytoplasmic insulin staining to specifically detect apoptotic beta cells.
TUNEL is based on tranferase-mediated digoxigenin-labeling of apoptotically
cleaved free DNA nick ends. The final exposure to a chemiluminescent dye (CSPD)
results in brown nuclei detected under light microscope. Insulin positivity was
detected by exposure to guineapig anti-porcine insulin preparation following
conjugation with biotinylated IgG and peroxidase-conjugated streptavidin. The
cytoplasms were stained red by the reaction product of the used AEC-substrate.
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The viability of primary human islets was detected and illustrated by a double
staining with calcein and ethidium homodimer-1 performed according to the
instructions of the commercial live/dead cell assay kit (L-3224, Molecular Probes).
The stained cells were analyzed by fluorescent microscopy showing viable, esterase
positive cells in green and dead cells in red.
4.2. Southern blot analysis  (II, IV)
DNA was isolated by a similar commercial system (Apoptotic DNA Ladder Kit,
Boehringer Mannheim) from all cell/islet preparations followed by RNase-treatment
and spectrophotometric quantification. 2 to 3 µg of total DNA per sample was
digoksigenin-labeled by transferase, electrophoresed through an agarose gel and
detected with antibody-dependent chemiluminiscence. Apoptotic human testis DNA
served as a positive control. DNA fragmentation was observed as a ladder pattern on
x-ray film.
4.3. Electron microscopy  (I, III)
Preparations of human islets and fetal porcine islets were similarly pretreated (2.5 %
glutaraldehyde fixation for two hours followed by two rinses with phosphate buffer)
to prepare samples for electron microscopic analysis of cell death. The fixed samples
were then sent in phosphate buffer to Brussels for further analysis in Prof. L.
Bouwens’ laboratory. There the samples were embedded in Spurr resin and
counterstained with uranyl acetate and lead citrate followed by analysis under electron
microscope. Specific signs for apoptotic and necrotic cell deaths and characteristics of
beta cells were searched and documented.
5. Analyses of cellular functions
5.1. Measurement of intracellular insulin and DNA contents  (I, II, III)
To confirm the viability and functionality of both primary islets and insulinoma cells
their intracellular insulin and DNA contents were measured. The cell samples were
first ultrasonically homogenized in redistilled water followed by splitting into separate
samples for DNA and insulin measurements. DNA was analyzed in duplicate by a
fluorometric method (Hinegardner, 1971) and insulin by a commercial RIA (DPC,
Los Angeles).
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5.2. Dynamic insulin release  (I, III)
The functionality of primary islets was analyzed by dynamic insulin secretory
response to stimulation by glucose and theophylline. This was done using a perifusion
system described previously (Otonkoski et al., 1999). The flow rate was 0.25 ml / min
and fractions were collected every four minutes. The concentrations of insulin in the
fractions were measured by a commercial RIA kit (DPC, Los Angeles).
5.3. MTT analysis  (II, III)
This analysis was performed to measure the metabolic viability of the H2O2 and/or L-
cysteine treated INS-1 cells and of PFP cells treated with guanidine-HCl and/or
infected with CVB5. Briefly, the cells were first incubated for 120 min with 0.5
mg/ml MTT and 16.7 mM glucose in KRB followed by dissolving the formazan
crystals with 0.04 N HCl in isopropanol. The result was recorded as optical densities
at 550 nm by a Victor2 multilabel counter (Janjic and Wollheim, 1992).
5.4. Nucleotide measurement (III, IV)
In order to rate the metabolic activity of beta cells, the level of ATP and ADP were
measured since their production directly correlates to the level of glucose oxidation.
By the side of the MTT analysis, these measurements were performed to test the
toxicity of G-HCl and its protective capacity against CVB5 induced functional
damage. Briefly, the samples were first abolished of infectivity by acidic treatments
after which the nucleotide levels were measured by spectrofluorometry. The level of
NADH was simultaneously measured to proportion the ATP level to the cell number.
As an indicator of the deteriorating energy metabolism, the levels of purine nucleotide
catabolism products (xanthine and hypoxanthine) in MIN6-cell culture media were
measured according to the same spectrofluorometric protocol after anti-viral acidic
treatment. The NAD level was simultaneously measured to proportion the data to cell
number.
6. Nitrite and inducible nitric oxide synthase (iNOS) measurements (I, IV)
To examine the role of nitric oxide in the process of virus induced beta cell death, the
level of nitrite was measured from the culture medium samples collected during the
first week of infection. After treatments nitrite was spectrophotometrically measured
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at 550 nm by a Victor2 (Wallac) multilabel counter using sodium nitrate as standard
(Green et al.  1982).
For the detection of inducible nitric oxide synthase (iNOS) semiquantitative RT-PCR
with specific primers for iNOS and GAPDH was run using 34 and 31 cycles
respectively (Pavlovic et al.  1999). The result was densitometrically quantified as a
ratio of iNOS/GAPDH.
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RESULTS AND DISCUSSION
1. Mechanisms of beta cell death during productive coxsackievirus infection
    (I, III, IV)
1.1. Human islets (I)
As referred to earlier, enteroviruses often establish subclinical viraemia in vivo but
also fulminant phenotypes are possible. As an example, the diabetic strain of
coxsackievirus B4 has been reported to lead to aggressive, lytic destruction of islet
tissue (1979, Yoon et al). To understand the mechanisms of virus-mediated beta cell
death in more detail we first infected isolated human islets in productive conditions
with prototype strains of CVB3, CVB4, CVB5, CVA9 and the diabetic strain of
CVB4 (E2). CVA9 was included because of its genetic similarity to CVBs and
previous epidemiologic link to the pathogenesis of T1D (Chang et al, 1992; Roivainen
et al, 1998). Since no strategies existed to study the viral effects on beta cells in vivo,
optimal in vitro culture conditions were prepared for this purpose.
In addition to the diabetogenic CVB4-E2 strain, all tested serotypes were able to
infect human islets. All CVB-infected cultures were detected with primary
morphological changes already after one to two days of infection. At this early time
point the morphology was predominantly characterized by nuclear pyknosis (40 % of
all cells). Apoptosis was mostly increased by CVB5 (5.9 %). By seven days, all CVB-
infected cultures were damaged by secondary necrosis. However, even at this point
some islets managed to maintain sound morphology and viability possibly due to the
metabolic heterogeneity of beta cells. It is of importance to notice the fact that
experimental cell culture systems often lack neighboring phagocytic cells responsible
for elimination of the apoptotic cells in vivo. Due to this, secondary necrotic cells may
emerge with cytolytic characteristics and thus complicate the interpretation of the cell
death pattern.
After one week of infection the insulin secretory capacity was most dramatically
perturbed by CVB3 and CVB5. All tested CVBs decreased the intracellular insulin
content by 40 to 65%. The expression level of inducible nitric oxide synthase (iNOS)
was detected unchanged and it was thus concluded that nitric oxide did not mediate
beta cell damage.
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Interestingly CVA9 infected cells preserved high viability similarly to uninfected
control cells. Furthermore, no signs of decreased insulin secretory capacity or
intracellular insulin content were observed. It could thus be speculated that CVA9
might cause a persistent infection of islets in vivo, which could then result in the
initiation or acceleration of beta cell specific autoimmunity.
1.2. Porcine fetal islets (III)
The model of culture-enriched porcine islet cells has been evaluated suitable for
studies on the effects of virus infection in respect to the pathogenesis of T1D
(Roivainen et al,  2001). Coxsackieviruses replicate well in porcine islets. In
comparison to human islets, the porcine endocrine cells are more susceptible to virus
induced damage perhaps due to their fetal, immature nature (Roivainen et al, 2001).
This phenomenon was also observed in our experiments, in which CVB5 infection
killed up to 80% of cells in only two days. The mechanism was predominantly
necrotic, though slight apoptosis was observed similarly to the productive CVB-
infection in human islets.
1.3 Insulin producing MIN6 cells (IV)
MIN6 cells, a mouse derived insulin producing cell line characterized by good
glucose responsiveness, were productively infected with prototype strain of CVB5.
The virus replicated well in these cells. However, in comparison to primary cells
MIN6 cells were observed with an apparent potential to resist CVB5 infection.
Productive infection resulted in gradual increase of necrosis as the dominant form of
cell death. After two days approximately 35% of cells were dead, ending up with 60%
mortality in one week. Out of the total cell mass only 4% and 2.5% died through
apoptosis at the previously mentioned timepoints, respectively. Thus, apoptosis was
only slightly and transiently increased. The CVB5-induced cell death pattern followed
the one described in human islets and PFP cells.
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2. Models of slowly progressing coxsackievirus B5 infection
     -Description of the pattern of beta cell death  (III, IV)
These studies were undertaken to clarify the mechanisms of coxsackievirus mediated
beta cell death in two different settings intended to resemble the conditions associated
with a slowly progressing infection in vivo. An attack by a foreign microorganism
induces a defense response in the immune system in order to maintain the status quo
and viability of the host. Due to this fact, no infection invading a normal, functioning
organism is ever freely productive. Thus, our primary hypothesis was that a restricted
infection created by treatment with an antiviral agent could mimic the trends and
effects of a slowly progressing infection in vivo. A number of pharmacological agents
with specific characteristics to inhibit various individual steps of the cycle of viral
multiplication have been developed. One of these, guanidine hydrochloride (G-HCl),
specifically inhibits RNA replication and release of small, unenveloped viruses into
which category coxsackieviruses are included (Rightsel et al, 1961). On established
cell lines, low concentrations of G-HCl (from 0.1 to 2 mM) are reported to function
strictly anti-virally without affecting the cellular functionality or structural viability
(Pfister and Wimmer, 1999). In a recent study on poliovirus infected Hela-cells, G-
HCl-mediated restriction of infection resulted in a switch from pyknotic to apoptotic
cell death. Furthermore, the induction of apoptosis was inhibited by a pan-caspase
inhibitor (Agol et al, 1998). The protocol of Agol et al. was used as a guideline in our
experiments on fetal porcine islets.
In vivo even a small amount of virus particles is enough to establish a local infection.
Based on this knowledge we hypothesized, that inoculation of host cells with a low
amount of infective viral particles (low multiplicity of infection) could also resemble
the situation in vivo. Moreover, coxsackievirus infections often remain subclinical in
vivo, which might be in concert with a small virus load in the target tissue. In order to
enable comparisons between different experimental infections it is crucial to
somehow standardize the infective conditions. For this purpose, the concept of
multiplicity of infection (M.O.I.) has previously been created. By definition M.O.I.
displays the number of infective virus particles per cell during an experimental viral
exposure in a cell culture model. In general, the higher the M.O.I. the more efficient
the progress of infection assuming that the cells exposed are susceptible and support
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the multiplication of the specific virus. Together with the strain and serotype of the
virus and host-related factors, M.O.I. probably affects both the outcome of infection
and the mechanism of host cell death.
2.1. Guanidine-HCl increases the viability of CVB5-infected porcine islet cells
       but does not preserve their functional integrity
We infected fetal porcine islets with the prototype strain of apparent high multiplicity
preparation of CVB5. G-HCl was added into culture media immediately after viral
exposure in three different concentrations: 0.1 mM, 0.5 mM and 1 mM. Virus growth
was inhibited significantly by the 0.5 mM concentration and blocked totally at 1 mM.
Analyzed by nuclear double staining G-HCl dose-dependently protected the infected
cells with 1 mM concentration being the lowest effective in preserving viability. It
significantly increased the number of living cells at both early (2 to 3 days) and later
(5 to 7 days) timepoints of infection. All tested concentrations of G-HCl were
nontoxic in control cells revealed by intact MTT and ATP measurements. Regardless
of these results and the fact of using exclusively low, strictly anti-viral concentrations
of G-HCl, the unfortunate outcome of the dynamic insulin release assay showed
perturbance of glucose-responsiveness. These data indicate that G-HCl probably
disturbs some step distal to glucose metabolism in the pathway leading from glucose
stimulus to insulin secretion in beta cells. Thus, more physiological nontoxic viral
inhibitors need to be developed in the future.
2.2. Guanidine-HCl mediates a switch in CVB5-induced cell death pattern
Simultaneously with increasing the viability of infected cells through decreased
necrosis, treatment with 1 mM G-HCl increased the amount of apoptotic cells. This
was ascertained by means of nuclear double staining and electron microscopy. The
present phenomenon is in concert with the earlier mentioned observations on
poliovirus infected HeLa-cells (Agol et al, 1998). It has further coherence to previous
data on Theiler's murine encephalomyelitis virus (member of the family
Picornaviridae) and human immunodeficiency virus (HIV), which kill susceptible
cells lytically but restricted cells via apoptosis (Jelachich and Lipton, 1996; Martin et
al.  1994).
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Although it is too early to speculate on the possible implications of this phenomenon
for the pathogenesis of virally induced diabetes, we appreciate the likelihood of it
being consistent with the hypothesis of beta cell apoptosis resulting from a local
enterovirus infection possibly in combination with the following production and
release of cytokines within the pancreas (Horwitz et al, 1998; Mandrup-Poulsen,
2001).
2.3. Low vs high multiplicity of CVB5 infection in MIN6 cells and human islets
We infected both MIN6 cells and adult human islets with preparations of either high
(> 1000) or low (< 0.5) M.O.I. of prototype CVB5. Both multiplicities reached the
same level of viral growth by three days, although the low M.O.I. culture achieved the
maximum at a slower pace. As mentioned earlier, MIN6 cells show some resistance
against CVB5 infection. Analyzed by nuclear double staining, during the high M.O.I.
conditions the viability of MIN6 cells decreased slowly compared to primary cells. By
six days 60% of MIN6 cells had died. Expectedly, destruction proceeded even slower
in the low M.O.I. culture, where the death rate was only 30% after six days of
infection. In human islets the high M.O.I. CVB5 infection lytically ruined the islet
morphology in seven days, whereas islets inoculated with low M.O.I. preserved sound
integrity.
2.4. Multiplicity of infection -dependent pattern of beta cell death
The morphology-based scoring of cell death after nuclear double staining revealed
high M.O.I. CVB5 infection to result in steadily increasing necrosis as the dominant
form of MIN6-cell death. Apoptosis was induced transiently, peaking on day two.
Instead, within cells inoculated with low M.O.I. both apoptosis and necrosis were
induced in moderate levels and the number of apoptotic cells increased linearly with
time. Furthermore, the apoptosis/necrosis ratio increased dramatically during low
M.O.I. but decreased during high M.O.I. culture clearly illustrating the multiplicity-
dependent patterns of cell death.
A similar phenomenon was observed in human islets. TUNEL+Insulin staining
showed an increasing amount of apoptotic beta cells at the margins of islets on both
days four and seven after low M.O.I. CVB5 infection. Similar results were obtained
from two other nuclear double stainings performed. As mentioned earlier, islets
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inoculated with high M.O.I. instead showed almost totally ruined morphology after
one week of infection. These observations were ascertained by Southern blot analysis
of DNA fragmentation from both MIN6 cells and human islets at the timepoint of 4
days. Samples of both cell preparations cultured in low M.O.I. conditions showed a
classical ladder-pattern characterizing DNA fragmentation. Similar patterning was
evident in a weaker fashion in the sample of high M.O.I. conditions, as expected by
the previous staining analyses.
According to these data apoptosis has a pronounced role as a mechanisms of beta cell
death after low multiplicity of CVB5 infection. Thus, both of the models created
(based on G-HCl restriction and low M.O.I.), result in increased apoptotic beta cell
death, consistent with the hypothesis that this also occurs during a pancreatic
enterovirus infection in vivo.
2.5. Nitric oxide (I, IV)
The recognition of the role of apoptosis during the process of virus mediated beta cell
death during low M.O.I. conditions raised interest towards the pathway mediating this
response. Nitric oxide (NO), known to hold antiviral properties, is considered
important in the immune response against coxsackievirus invasion (Saura et al.  1999;
Zaragoza et al.  1998). It has also been presented to act as a mediator of apoptotic cell
death (Moncada and Erusalimsky, 2002; Sandau et al.  1997). However, tested on
both human islets and MIN6 cells, we found the CVB-mediated cell death not to
depend on NO and thus this pathway is also excluded as a mediator of the observed
apoptosis. Our results are consistent with the previous observations on NO-
independent cytokine- and dsRNA-mediated apoptosis in primary rat islets (Liu et al.
2000a; Liu et al.  2002).
3.   Redox balance in stressed beta cells (II, IV)
3.1. Antioxidants protect against oxidative beta cell injury
Beta cells are very vulnerable to oxidative stress because of the weak capacity of their
intracellular antioxidative machinery in comparison to other cell types (Lenzen et al.
1996; Tiedge et al. 1997). As previously concluded, oxidative molecules most
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probably contribute to the process of beta cell damage and development of T1D.
Thus, we analyzed the mechanisms of experimental oxidative injury in insulin
producing cells (INS-1 and RINm5F) and tested the capacity of the antioxidant, L-
cysteine, to protect from the hypothesized damage.
Exposure to either 50 µM or 100 µM hydrogen peroxide resulted in distinct
morphological damage and impaired cellular functions evidenced by decreased
intracellular insulin content. Furthermore the intracellular concentration of glutathione
(GSH) decreased. Dose-dependent administration of L-cysteine partially protected
from both the structural and functional oxidative damage observed by means of
nuclear double staining and MTT-analysis. The protective 1 mM concentration of L-
cysteine also increased the intracellular GSH-reserve.
Glutathione represents a crucial constituent of the intracellular antioxidative defense
machinery and its synthesis is dependent on the availability of L-cysteine. We
observed that L-cysteine, administered extracellularly as a substituent antioxidant, is
protective against oxidative damage in insulin producing cells. Direct recognition and
capture of reactive molecules likely play the most significant role in the protective
process, but according to the detected raised intracellular GSH-level also thiol
synthesis is utilized to achieve protection. Evidenced by dose-dependent protection
and aggravated damage by higher concentrations, the therapeutic dose has to be
carefully evaluated to avoid counteractive side effects.
3.2. Mechanisms of ROS-induced beta cell death
Oxidative stress may stimulate various signaling pathways with varying functions,
targets and purposes. Apoptotic death is one outcome particularly favored by
moderate level of oxidative stress (Lennon et al. 1991; Hampton and Orrenius, 1997).
Out of the tested concentrations, 50 µM hydrogen peroxide represents a strong
physiological oxidative burst. In these conditions especially, distinct signs of DNA
fragmentation were detected when analyzed by electrophoresis. Furthermore, this
apoptotic patterning was abolished by 1 mM L-cysteine, the only concentration also
protecting the viability. Supporting our observations, previous studies also
acknowledge the anti-apoptotic potential of antioxidants, especially GSH and its
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precursor N-acetylcysteine (Melnick, 1996; Heussler et al.  1999; Kelso et al.  2001;
Sato et al.  2002; Naderi et al.  2003; Celli et al.  1998; Lee et al.  2001).
3.3. Effects of a coxsackievirus infection on redox balance in insulin producing
cells
Attacks by foreign pathogens, like viruses, stimulate the host to produce protective
agents. This excites and burdens the cellular metabolism, which inevitably results in
the production and release of oxidative radicals in large amounts (Fernandez-Checa et
al.  1998). Also direct killing by the attacking microbe may result in leakage of these
radicals from the host cell. As mentioned earlier, the antioxidative capacity of the beta
cell is low in comparison to other cell types. Thus, even moderate oxidative stress
might rapidly use up the antioxidant reserves and even by itself induce detrimental
damage. This situation is even more likely when increased free ROS circulate
simultaneously with other detrimental molecules such as cytokines, likely to occur
due to viral invasion.
In our experimental setting, a high multiplicity CVB5-infection resulted in gradual,
permanent decrease of the major intracellular antioxidant, glutathione (GSH). Instead,
during low M.O.I. the GSH reserve recovered totally from the initial decrease in the
cells that remained viable. This observation is in concert with previous data on CVB3-
induced myocarditis in vivo, which associated with a similar thiol-profile (Kytö et al,
unpublished data). One could consider the recovering thiol-profile to characterize a
more physiological stress response, which would logically follow a low-grade
infection. Moreover, as mentioned before, such a moderate stress has also previously
been linked to the induction of apoptotic cell death (Lennon et al. 1991; Hampton and
Orrenius, 1997). Further in line was our Northern blot analysis revealing the
expression level of γ-glutamylcysteine synthetase, the rate-limiting enzyme in
glutathione synthesis, to increase dramatically in response to high M.O.I. CVB5-
infection and moderately in response to low M.O.I. CVB5-infection. Taken together
these data implicate a possible protective role for the intracellular antioxidative
system against virus induced beta cell damage.
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SUMMARY AND CONCLUSIONS
Enterovirus infections are considered as potential triggers of the autoimmune response
towards pancreatic beta cells and the following development of T1D. Same
characteristics fit the oxidative molecules, which might aggravate an infective
process. The diabetogenic potential is shared between various serotypes in the group
of enteroviruses including coxsackieviruses, which represent a widely studied
subgroup. These studies were undertaken to uncover the mechanisms of
coxsackievirus- and experimental oxidative stress -induced beta cell death and further
to reveal their possible interactions in the process of beta cell damage.
Based on the results obtained from the individual studies included in this thesis
project the following conclusions can be presented:
1. Coxsackieviruses infect and replicate well in insulinoma cells, fetal porcine
pancreatic islet cells and adult human islets. Thus these models are considered
suitable for studies concerning virus-mediated effects on beta cells.
2. Productive coxsackie B virus infections of high multiplicity induce primarily
nuclear pyknosis in human beta cells, which finally leads to lysis and impaired
metabolic functions. In fetal porcine islets the process is more rapid and leads
to extensive necrosis in only two days. Based on data from serotype A9 as a
representative of coxsackie A viruses, infections due to this subgroup are less
aggressive and the viability and functionality of beta cells are maintained.
3. When restricting the replication of coxsackievirus B5 by guanidine
hydrochloride in porcine fetal islets, their viability increases dramatically
through decreased necrotic cell death. Simultaneously apoptosis is induced. A
similar phenomenon was observed in human islets and MIN6 insulinoma cells
after inoculation with low multiplicity of coxsackievirus B5. In comparison to
the necrotic outcome during high multiplicity infection, low multiplicity
conditions favor apoptotic beta cell death. We hypothesize the restrictive and
low multiplicity conditions to resemble the situation in vivo after a viral attack
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and thus propose beta cell apoptosis as a possible outcome of a pancreatic
infection.
4.  Beta cells are vulnerable to oxidative stress due to their weak antioxidative
competence. Our results show a moderate concentration of hydrogen peroxide
to induce beta cell apoptosis, while in higher amount necrosis follows as the
dominant form of death. 1 mM L-cysteine, the precursor of glutathione,
efficiently inhibits oxidative beta cell death, but turns toxic in higher
concentrations. By this model of experimental oxidative stress one may
conclude that both oxidants and antioxidants act in dose-dependent manner in
beta cells. Efficient protection against moderate, in vivo-like, oxidative stress
may be achieved by carefully evaluated antioxidant supplementation.
5. Virus infections attract the cells of the immune system to produce and secrete
cytokines and result further in overproduction of oxidative molecules. We
show evidence that a productive coxsackievirus B5 infection of high
multiplicity results in deterioration of the beta cell glutathione balance, while
during low multiplicity of infection the cells maintain a better viability and are
capable of recovering their glutathione reserves. This may be interpreted to
indirectly demonstrate a virus-induced stimulation of oxidant production in a
dose dependent manner. Furthermore, these data indicate that beta cells use
their scarce antioxidative capacity to defend themselves against an infective
process. This renders antioxidants important in the battle against virus-induced
beta cell injury.
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CONCLUDING REMARKS
The pathogenesis of type I diabetes has long been acknowledged to potentially
associate with an enterovirus infection and increased oxidative stress. Most of these
data derive from epidemiological and clinical patient-based studies. The problem
associated with more detailed research on the mechanisms of beta cell damage is the
limitation to study this process in vivo. Thus, insulin producing cell lines and several
ex vivo tissue culture models have been created, evaluated and used to serve this
purpose.
In the present set of studies we have used in vitro models to study in detail the
mechanisms of beta-cell death induced by enteroviral infection or oxidative stress.
Acknowledging the limitations of these models, we may conclude that apoptotic beta
cell death represents a favored outcome of a slowly progressing enterovirus infection
and of moderate oxidative stress. Furthermore, a physiological redox balance and
antioxidative supplementation may protect from both oxidative and virus induced beta
cell damage. Detailed knowledge of the mechanisms of beta cell damage is essential
for the development of new anti-viral and anti-oxidative strategies in order to protect
pancreatic beta cells.
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